Growth Metrics

Cytek Biosciences (CTKB) Other Working Capital Changes (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Other Working Capital Changes for 6 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 3.95% year-over-year to $1.7 million, compared with a TTM value of $3.6 million through Dec 2025, down 3.64%, and an annual FY2025 reading of $3.6 million, down 3.64% over the prior year.
  • Other Working Capital Changes was $1.7 million for Q4 2025 at Cytek Biosciences, up from $284000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $6.4 million in Q3 2022 and bottomed at -$5.6 million in Q4 2022.
  • Average Other Working Capital Changes over 5 years is $1.5 million, with a median of $1.7 million recorded in 2021.
  • The sharpest move saw Other Working Capital Changes tumbled 1360.78% in 2022, then skyrocketed 2050.74% in 2024.
  • Year by year, Other Working Capital Changes stood at -$385000.0 in 2021, then crashed by 1360.78% to -$5.6 million in 2022, then surged by 174.4% to $4.2 million in 2023, then crashed by 60.09% to $1.7 million in 2024, then rose by 3.95% to $1.7 million in 2025.
  • Business Quant data shows Other Working Capital Changes for CTKB at $1.7 million in Q4 2025, $284000.0 in Q3 2025, and $238000.0 in Q2 2025.